Medicines, 2014
Shortlist up to four to read them side by side.
1,562 medicine recalls FDA’s Enforcement Report published in 2014, newest first; 18,075 in all since 2012.
FDA’s medicine recalls, as its Enforcement Report classifies them, from June 2012. Lists of FDA’s records can’t be saved for alerts: openFDA asks that its data not be used to alert the public (openFDA); FDA’s own emails do that. Copied Nov 5, 2026.
1,562of 1,562 medicine recallsshown with your filters
The list
- Medicine recall HCG (Human Chorionic Gonadotropin) 125 units/ 0.1 mL drop, 5 mL bottle Incorrect/Undeclared Excipients: Specific drug products were compounded with an incorrect solvent. Class IIFDA’s classJul 9, 2014in FDA’s Enforcement ReportWisconsinthe one state its words name PublishedJul 9, 2014ClassClass IIStatusTerminatedWhereWisconsin
- Medicine recall HCG 125U/Tab Tablet Tritu, 50 tablets per bottle Incorrect/Undeclared Excipients: Specific drug products were compounded with an incorrect solvent. Class IIFDA’s classJul 9, 2014in FDA’s Enforcement ReportWisconsinthe one state its words name PublishedJul 9, 2014ClassClass IIStatusTerminatedWhereWisconsin
- Medicine recall HCG (Human Chorionic Gonadotropin) 200 units/ 0.1 mL drops Incorrect/Undeclared Excipients: Specific drug products were compounded with an incorrect solvent. Class IIFDA’s classJul 9, 2014in FDA’s Enforcement ReportWisconsinthe one state its words name PublishedJul 9, 2014ClassClass IIStatusTerminatedWhereWisconsin
- Medicine recall HCG (Human Chorionic Gonadotropin) + Methylcobalamin (Methyl B12), 1500 units + 1000 mcg/mL drop, 8 mL bottle Incorrect/Undeclared Excipients: Specific drug products were compounded with an incorrect solvent. Class IIFDA’s classJul 9, 2014in FDA’s Enforcement ReportWisconsinthe one state its words name PublishedJul 9, 2014ClassClass IIStatusTerminatedWhereWisconsin
- Medicine recall Gemcitabine For Injection USP, 1 g, (lyophilized), For Intravenous Use Only, Sterile Single Use Vial Lack of Assurance of Sterility: A particle excursion for a different batch of the same product may lead to a lack of sterility assurance. Class IIFDA’s classJul 2, 2014in FDA’s Enforcement ReportOhiothe one state its words name PublishedJul 2, 2014ClassClass IIStatusTerminatedWhereOhio
- Medicine recall Dextroamphetamine Sulfate Tablets, USP, 10 mg, 100-count bottles Failed Impurities/Degradation Specifications: this product is being recalled due to an out of specification test result for impurities during stability testing. Class IIFDA’s classJul 2, 2014in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedJul 2, 2014ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Pristiq (desvenlafaxine) Extended-Release Tablets 50 mg, 30 count bottle Presence of Foreign Tablets/Capsules: Pfizer is recalling 50 mg Pristiq (desvenlafaxine) extended release tablets because a single Pristiq 100 mg tablet was… Class IIFDA’s classJul 2, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJul 2, 2014ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Muro 128 (sodium chloride) hypertonicity ophthalmic ointment, 5% Crystallization: Crystal precipitate formation and an increase in the number of complaints associated with a gritty, sand-like feeling in the eye. Class IIFDA’s classJul 2, 2014in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedJul 2, 2014ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Sodium Chloride Hypertonicity Ophthalmic Ointment, 5%, 1/8 oz. Crystallization: Crystal precipitate formation and an increase in the number of complaints associated with a gritty, sand-like feeling in the eye. Class IIFDA’s classJul 2, 2014in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedJul 2, 2014ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Captomer [succinic acid (from 100 mg DMSA)] capsules, 65 mg, 45-count bottles Marketed Without An Approved NDA/ANDA: Captomer and Captomer-250 are marketed as dietary supplements and labeled to be sourced from Dimercaptosuccinic Acid… Class IIFDA’s classJun 25, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJun 25, 2014ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Captomer-250 [succinic acid (from 250 mg DMSA)] capsules, 162 mg, 45-count bottles Marketed Without An Approved NDA/ANDA: Captomer and Captomer-250 are marketed as dietary supplements and labeled to be sourced from Dimercaptosuccinic Acid… Class IIFDA’s classJun 25, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJun 25, 2014ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall TEV-TROPIN [somatropin (rDNA origin) for injection] 5 mg Chemical Contamination: TEV-TROPIN [somatropin (rDNA origin) for injection] may contain silicone oil due to leakage of a leaking line during the freeze-drying… Class IIFDA’s classJun 25, 2014in FDA’s Enforcement ReportPennsylvaniathe one state its words name PublishedJun 25, 2014ClassClass IIStatusTerminatedWherePennsylvania
- Medicine recall Vancomycin Hydrochloride Capsules, USP, 250 mg. 20 Capsules on 2 x 10 Capsule Blister Cards Subpotent Drug. Class IIFDA’s classJun 25, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJun 25, 2014ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Foradil Aerolizer (formoterol fumarate inhalation powder), 12 mcg per capsule, 60 Capsules Failed Stability Specification; out of specification result for particle size distribution during stability testing Class IIIFDA’s classJun 25, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJun 25, 2014ClassClass IIIStatusTerminatedWhereNationwide
- Medicine recall Polidocanol 0.5% Solution for Injection, Polidocanol (Laureth 9) 5mg, 50 mL, JOHN HOLLIS Pharmacist Inc, 110… Lack of Assurance of Sterility: Lack of sterility assurance in compounded aseptically filled injectable products. Class IIFDA’s classJun 25, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJun 25, 2014ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Liver Derivative Complex for injection, each mL contains: Liver Derivative Complex 25.5mg, also contains:… Lack of Assurance of Sterility: Lack of sterility assurance in compounded aseptically filled injectable products. Class IIFDA’s classJun 25, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJun 25, 2014ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall CYANOCOBALAMIN FOR INTRAMUSCULAR OR SUBCUTANEOUS USE ONLY, Each mL contains: Cyanocobalamin 1000 mcg, , Also… Lack of Assurance of Sterility: Lack of sterility assurance in compounded aseptically filled injectable products. Class IIFDA’s classJun 25, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJun 25, 2014ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Polidocanol 5% Solution for Injection, each mL contains Polidocanol (Laureth 9) 50 mg, also contains Sterile… Lack of Assurance of Sterility: Lack of sterility assurance in compounded aseptically filled injectable products. Class IIFDA’s classJun 25, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJun 25, 2014ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Testosterone Cypionate for Injection, each mL contains Testosterone Cypionate 200 mg, also contains: Cotton… Lack of Assurance of Sterility: Lack of sterility assurance in compounded aseptically filled injectable products. Class IIFDA’s classJun 25, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJun 25, 2014ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall MIC PLUS B12, Adenosine, L-Carnitine, Contains: Methionine 15mg, Choline 100mg, Inositol 50mg, B 12, 0.200mg,… Lack of Assurance of Sterility: Lack of sterility assurance in compounded aseptically filled injectable products. Class IIFDA’s classJun 25, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJun 25, 2014ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Mannitol 5% Solution for injection, Mannitol 50 mg, also contains Sterile Water for Injection, Chlorobutanol… Lack of Assurance of Sterility: Lack of sterility assurance in compounded aseptically filled injectable products. Class IIFDA’s classJun 25, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJun 25, 2014ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Levocarnitine Solution for injection, l-Carnitine 50 mg, Also Contains Sterile Water for Injection and Benzyl… Lack of Assurance of Sterility: Lack of sterility assurance in compounded aseptically filled injectable products. Class IIFDA’s classJun 25, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJun 25, 2014ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall METHYLCOBALAMIN FOR INTRAMUSCULAR OR SUBCUTANEOUS USE ONLY, Methylcobalamin 1000 mcg, Also Contains: Benzyl… Lack of Assurance of Sterility: Lack of sterility assurance in compounded aseptically filled injectable products. Class IIFDA’s classJun 25, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJun 25, 2014ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Papaverine HCl 30 mg, Phentolamine Mesylate 1 mg, Alprostadil 20 mcg, a) 5 mL and b) 10 mL, JOHN HOLLIS… Lack of Assurance of Sterility: Lack of sterility assurance in compounded aseptically filled injectable products. Class IIFDA’s classJun 25, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJun 25, 2014ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall B-Complex/Adenosine Inj sol, Adenosine-5-Monophosphate 0.03g, Choline Chloride 0.01g, Cyanocobalamin 0.3mg,… Lack of Assurance of Sterility: Lack of sterility assurance in compounded aseptically filled injectable products. Class IIFDA’s classJun 25, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJun 25, 2014ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Papaverine HCl 30 mg, Phentolamine Mesylate 2 mg, Alprostadil 40 mcg, a) 5 mL and b) 10 mL, JOHN HOLLIS… Lack of Assurance of Sterility: Lack of sterility assurance in compounded aseptically filled injectable products. Class IIFDA’s classJun 25, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJun 25, 2014ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Papaverine HCl 30 mg, Phentolamine Mesylate 1 mg, a) 5 mL and b) 10 mL, JOHN HOLLIS Pharmacist, Inc 110 20th… Lack of Assurance of Sterility: Lack of sterility assurance in compounded aseptically filled injectable products. Class IIFDA’s classJun 25, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJun 25, 2014ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Papaverine HCl 30 mg, Phentolamine Mesylate 2 mg, Alprostadil 20 mcg, 10 mL, JOHN HOLLIS Pharmacist, Inc 110… Lack of Assurance of Sterility: Lack of sterility assurance in compounded aseptically filled injectable products. Class IIFDA’s classJun 25, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJun 25, 2014ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Papaverine HCl 30 mg, Phentolamine Mesylate 0.5 mg, Alprostadil 10 mcg, a) 5 mL and b) 10 mL, JOHN HOLLIS… Lack of Assurance of Sterility: Lack of sterility assurance in compounded aseptically filled injectable products. Class IIFDA’s classJun 25, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJun 25, 2014ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Papaverine HCl 30 mg, Phentolamine Mesylate 1 mg, Alprostadil 10 mcg, a) 5 mL and b) 10 mL, JOHN HOLLIS… Lack of Assurance of Sterility: Lack of sterility assurance in compounded aseptically filled injectable products. Class IIFDA’s classJun 25, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJun 25, 2014ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall LIPOTROPIC GOLD, Each mL contains: Levocarnitine 5 mg, Thiamine 50 mg, Riboflavin-5 phosphate 5mg,… Lack of Assurance of Sterility: Lack of sterility assurance in compounded aseptically filled injectable products. Class IIFDA’s classJun 25, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJun 25, 2014ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall PYRIDOXINE HCL, Pyridoxine HCl 100mg, Also Contans: Benzyl Alcohol, Sodium Chloride, Water, Hydrochloric… Lack of Assurance of Sterility: Lack of sterility assurance in compounded aseptically filled injectable products. Class IIFDA’s classJun 25, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJun 25, 2014ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Polidocanol 1% Solution for Injection, each mL contains Polidocanol (Laureth 9) 10 mg, also contains Sterile… Lack of Assurance of Sterility: Lack of sterility assurance in compounded aseptically filled injectable products. Class IIFDA’s classJun 25, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJun 25, 2014ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Venlafaxine HCl Extended-Release Capsules, 150 mg, 90-count Unit of Use bottles Presence of Foreign Tablets/Capsules: report of a foreign capsule with markings (TKN 250) and identified as a Tikosyn (dofetilide) capsule was found in a… FDA Class I, its most serious class Class IFDA’s class (needs attention)Jun 18, 2014in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedJun 18, 2014ClassClass IStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Midazolam 0.2 mg/2 mL 0.9% Sodium Chloride syringes, Total dosage: 0.4 mg per 2 mL Superpotent Drug: Product contains twice the stated amount of midazolam. FDA Class I, its most serious class Class IFDA’s class (needs attention)Jun 18, 2014in FDA’s Enforcement ReportIndianathe one state its words name PublishedJun 18, 2014ClassClass IStatusTerminatedWhereIndiana
- Medicine recall Pantoprazole Sodium, Delayed-release tablets, USP, 40 mg tablets, 100 Correct Labeled Product Miscart/Mispack: some cartons labeled as Pantoprazole Sodium Delayed-Release may contain correctly labeled blister cards of Lorazepam… Class IIFDA’s classJun 18, 2014in FDA’s Enforcement ReportIndianathe one state its words name PublishedJun 18, 2014ClassClass IIStatusTerminatedWhereIndiana
- Medicine recall vitaliKOR Ready When You Are, Fast Acting Formula Dietary Supplement capsules, 40 count bottle Marketed Without an Approved NDA/ANDA: FDA sampling found undeclared vardenafil and tadalafil in vitaliKOR capsules FDA Class I, its most serious class Class IFDA’s class (needs attention)Jun 18, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJun 18, 2014ClassClass IStatusTerminatedWhereNationwide
- Medicine recall Bella Vi INSANE Bee Pollen Dietary Supplement Capsules, 60 count bottles, www.BellaViProducts.com Marketed without an Approved NDA/ANDA; product was found to contain undeclared sibutramine & phenolphthalein FDA Class I, its most serious class Class IFDA’s class (needs attention)Jun 18, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJun 18, 2014ClassClass IStatusTerminatedWhereNationwide
- Medicine recall Bella Vi BTrim MAX Dietary Supplement capsules, 60 count bottles, www.BellaViProducts.com Marketed without an Approved NDA/ANDA; product was found to contain undeclared sibutramine & phenolphthalein FDA Class I, its most serious class Class IFDA’s class (needs attention)Jun 18, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJun 18, 2014ClassClass IStatusTerminatedWhereNationwide
- Medicine recall Bella Vi BTrim ULTIMATE BOOST Dietary Supplement capsules, 30 count bottles, www.BellaViProducts.com Marketed without an Approved NDA/ANDA; product was found to contain undeclared sibutramine & phenolphthalein FDA Class I, its most serious class Class IFDA’s class (needs attention)Jun 18, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJun 18, 2014ClassClass IStatusTerminatedWhereNationwide
- Medicine recall Bella Vi eXtreme ACCELERATOR Dietary Supplement Capsules, 30 count bottles, www.BellaViProducts.com Marketed without an Approved NDA/ANDA; product was found to contain undeclared sibutramine & phenolphthalein FDA Class I, its most serious class Class IFDA’s class (needs attention)Jun 18, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJun 18, 2014ClassClass IStatusTerminatedWhereNationwide
- Medicine recall Bella Vi INSANE AMP’D Dietary Supplement capsules, 60 count bottles, www.BellaViProducts.com Marketed without an Approved NDA/ANDA; product was found to contain undeclared sibutramine & phenolphthalein FDA Class I, its most serious class Class IFDA’s class (needs attention)Jun 18, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJun 18, 2014ClassClass IStatusTerminatedWhereNationwide
- Medicine recall Bella Vi AMP’D UP Advanced Weight Loss Dietary Supplement capsules, 60 count bottles, www.BellaViProducts.com Marketed without an Approved NDA/ANDA; product was found to contain undeclared sibutramine & phenolphthalein FDA Class I, its most serious class Class IFDA’s class (needs attention)Jun 18, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJun 18, 2014ClassClass IStatusTerminatedWhereNationwide
- Medicine recall REDUCE WEIGHT FRUTA PLANTA Capsules, 400 mg, supplied Marketed Without an Approved NDA/ANDA: Product was found to contain undeclared active pharmaceutical ingredient: Phenolphthalein. FDA Class I, its most serious class Class IFDA’s class (needs attention)Jun 18, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJun 18, 2014ClassClass IStatusTerminatedWhereNationwide
- Medicine recall JIANFEIJINDAN Activity Girl Capsules, 400 mg, supplied Marketed Without an Approved NDA/ANDA: Product was found to contain undeclared ingredient: N-di-desmethylsibutramine, an analog of sibutramine FDA Class I, its most serious class Class IFDA’s class (needs attention)Jun 18, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJun 18, 2014ClassClass IStatusTerminatedWhereNationwide
- Medicine recall Fruta BIO 400 mg capsules, supplied Marketed Without an Approved NDA/ANDA: Product was found to contain undeclared active pharmaceutical ingredients: Sibutramine and Phenolphthalein . FDA Class I, its most serious class Class IFDA’s class (needs attention)Jun 18, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJun 18, 2014ClassClass IStatusTerminatedWhereNationwide
- Medicine recall Super Fat Burning Bomb Capsules, 400 mg, supplied Marketed Without an Approved NDA/ANDA: Product was found to contain undeclared active pharmaceutical ingredients: Phenolphthalein and N-desmethylsibutramine FDA Class I, its most serious class Class IFDA’s class (needs attention)Jun 18, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJun 18, 2014ClassClass IStatusTerminatedWhereNationwide
- Medicine recall Pill for weight reduction, (Japanese Chinese Formula from Japan Hokkaido Cangye Pharmacy Co, Ltd) 400 mg,… Marketed Without an Approved NDA/ANDA: Product was found to contain undeclared active pharmaceutical ingredient: Phenolphthalein FDA Class I, its most serious class Class IFDA’s class (needs attention)Jun 18, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJun 18, 2014ClassClass IStatusTerminatedWhereNationwide
Nothing matches all of these.
Remove a filter to see more. Each one is a fact FDA’s record publishes, so a recall can be left out because its record is silent on it.
Source:
FDA, Drug recall enforcement reports. Released Nov 3, 2026. Updated weekly.
Recalls of food, medicines, medical devices, pet food and animal drugs are from the U.S. Food and Drug Administration (FDA). FDA does not endorse Hearth Record. openFDA: “Do not rely on openFDA to make decisions regarding medical care.”
Your shortlist0 of 4
Add one more to compare.